5 MINS READ
For a long time now, pharmaceutical organizations across the globe have been plagued with several challenges concerning the deluge of data they have to handle.
These can be summarized as the twin challenges of manually researching the changing regulatory guidelines to ensure better compliance and reducing re-work as a result of departmental silos within the organization and the non-availability of past records for reference on demand. These two issues lead to reduced operational efficiency, increased time, effort, and cost.
This paper addresses how these challenges can be holistically resolved by embracing a technology-centric approach to design a smart solution for regulatory adherence. This solution would provide actionable insights and facilitate precise, readily available, and contextual information that enables reference to literature on-demand, provides regulatory intelligence and accelerates response to health authority queries.
Empowering regulatory processes with machine intelligence
Regulatory departments of pharmaceutical companies are always expected to stay abreast with the ever-changing and evolving regulatory guidelines and ensure 100% compliance.
They are compelled to browse through various regulatory updates manually to understand the latest changes, global advancements, approval trends, clinical evaluation findings, regulatory filings, etc. However, such manual approach to tracking is almost always error-prone, time-consuming, and effort-intensive. In addition, within pharma organizations, regulatory data is usually stored in silos across various departments and/or locations. Multiple departments store Health Authority Queries (HAQs) in spreadsheets, making it difficult for other departments to access them for reference.
With ever increasing market demand, new regulations and evolving regulatory compliance requirements, the industry is facing diverse challenges to manage regulatory lifecycle and change management. At the site level, regulators are unable to quickly respond to changes proposed by pharma due to non-availability of required submission documents under assessment leading to increased cycle time, effort and cost.
With the help of a smart regulatory intelligence solution, life sciences organizations can reduce manual work and stay updated on the latest trends in the domain. Such solution would also help in limiting the number of submission queries received from Health Authorities (HA), reducing response time for HAQs, and centralizing all regulatory information for the entire organization. As it facilitates faster discovery of information, it can quickly indicate key factors during an unforeseen situation like the COVID-19 pandemic. Based on these findings, pharma organizations can decide between suspending or continuing an ongoing study or initiating a new study altogether.
What is Regulatory Intelligence (RI)?
Regulatory Intelligence leverages the power of automation, Artificial Intelligence (AI), Natural Language Processing (NLP), and real-time analytics to provide meaningful insights into regulatory processes.
The RI solution has two facets to it – market intelligence and operational intelligence.
Just as with Market Intelligence, the extracted information can be stored in a centralized repository with traceability for the original documents. Text-based content can then be indexed in the search engine to enable keyword-based search. Further, NLP can be leveraged to train the model continuously on extracted questions and enable context-based search rather than keyword-based ones to find similar HAQ responses from the past.
In addition, an AI-powered RI solution capable of processing text and image components can be leveraged to monitor regulatory guidelines updates and access documents in PDF, DOC, and XML formats thereby providing intelligent assessment of regulatory updates. A digital repository with advanced analytical capabilities over regulation updates can provide near real-time requirement prediction for new changes, to make sure that the requirements are completely met at the first submission. This effectively reduces assessment time, accelerates lifecycle management quality and regulator assessment, and enables timely market access.
An advanced RI solution should also provide personalization for users, including the option to perform contextual search, configure fields to be displayed on the screen, save searched queries for later use, provide ‘yes/no’ inputs on answer accuracy, etc. A real-time analytical capability in the tool will help identify various regulatory trends and provide insights through a cutting-edge rich visualization framework. Actionable insights provided by the tool will enhance decision-making capabilities, increase efficiency, and improve compliance. In addition, a user-friendly and intuitive mobile app can be created to provide the above information in a concise, crisp, and self-explanatory manner.
A robust regulatory intelligence platform drives efficiency in regulatory processing, improves stakeholder collaborations, promotes transparency, provides ease of requirement prediction and enables quality with data driven submissions.
By restructuring legacy processes and reimagining regulatory information with the help of digital technologies such as artificial intelligence, pharmaceutical organizations can operate more efficiently and respond with speed to any emerging critical situation.
The integrated Regulatory Intelligence solution facilitates the reuse of internal information and enables a more streamlined flow of global regulatory requirements. The need of the hour, thus, is to envisage a connected future with the aid of digital technologies and RI. Through its myriad capabilities and possibilities, it can help pharma organizations overcome critical challenges and assist them in their pursuit of building a smart enterprise.